• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying

    5/31/24 9:26:35 AM ET
    $BHB
    $CZR
    $EXEL
    $PCB
    Major Banks
    Finance
    Hotels/Resorts
    Consumer Discretionary
    Get the next $BHB alert in real time by email

    Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.

    Exelixis

    • The Trade: Exelixis, Inc. (NASDAQ:EXEL) Director Caligan Partners LP acquired a total of 425,000 shares at an average price of $20.55. To acquire these shares, it cost around $8.73 million.
    • What's Happening: On May 14, Stephens & Co. analyst Sudan Loganathan initiated coverage on Exelixis with an Equal-Weight rating and announced a price target of $23.
    • What Exelixis Does: Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer.

    Caesars Entertainment

    • The Trade: Caesars Entertainment, Inc. (NASDAQ:CZR) Director Michael E Pegram acquired a total of 10,000 shares at an average price of $31.96. To acquire these shares, it cost around $319,600.
    • What's Happening: On May 21, Raymond James analyst RJ Milligan initiated coverage on Caesars Entertainment with a Strong Buy rating and announced a price target of $55.
    • What Caesars Entertainment Does: Caesars Entertainment includes about 50 domestic gaming properties across Las Vegas (49% of 2023 EBITDAR before corporate expenses) and regional (48%) markets.

    Don’t forget to check out our premarket coverage here

    PCB Bancorp

    • The Trade: PCB Bancorp (NASDAQ:PCB) Director Sang Young Lee bought a total of 14,000 shares at an average price of $14.97. To acquire these shares, it cost around $209,541.
    • What's Happening: On April 25, PCB Bancorp posted downbeat quarterly earnings.
    • What PCB Bancorp Does: PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services.

    Bar Harbor Bankshares

    • The Trade: Bar Harbor Bankshares (NYSE:BHB) Director Scott G Toothaker bought a total of 4,476 shares at an average price of $25.82. The insider spent around $115,570 to buy those shares.
    • What's Happening: On April 18, Bar Harbor Bankshares posted upbeat quarterly earnings.
    • What Bar Harbor Bankshares Does: Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities.

    Check This Out: Top 4 Materials Stocks You May Want To Dump In Q2

    Get the next $BHB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BHB
    $CZR
    $EXEL
    $PCB

    CompanyDatePrice TargetRatingAnalyst
    Bar Harbor Bankshares Inc.
    $BHB
    3/16/2026$38.00Overweight
    Piper Sandler
    Exelixis Inc.
    $EXEL
    1/8/2026$48.00Overweight → Equal-Weight
    Morgan Stanley
    Caesars Entertainment Inc.
    $CZR
    1/8/2026$31.00Neutral → Positive
    Susquehanna
    Exelixis Inc.
    $EXEL
    1/5/2026$41.00Neutral → Underperform
    BofA Securities
    Caesars Entertainment Inc.
    $CZR
    12/15/2025$24.00Buy → Neutral
    Goldman
    Caesars Entertainment Inc.
    $CZR
    11/21/2025$23.00Neutral
    Citigroup
    Exelixis Inc.
    $EXEL
    11/18/2025Peer Perform
    Wolfe Research
    Caesars Entertainment Inc.
    $CZR
    11/18/2025$21.00Equal Weight
    Wells Fargo
    More analyst ratings

    $BHB
    $CZR
    $EXEL
    $PCB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Harrah's Oklahoma Officially Opens in Chandler

    First Caesars-managed casino in Oklahoma welcomes guests with ribbon-cutting, first bets and opening day celebration For hi-res images, please click here Harrah's Oklahoma is officially open, marking the first Caesars Entertainment-managed property in the state and a new destination for tourism and entertainment in Oklahoma. Developed in partnership with the Iowa Tribe of Oklahoma, the casino celebrated its grand opening with a ribbon-cutting ceremony featuring tribal and Caesars leadership, first gaming moments, local celebrity appearances, live entertainment and a fireworks finale. As part of the celebration, Oklahoma football legends Barry Switzer and Bob Stoops took part in ceremo

    4/9/26 3:00:00 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    Caesars Entertainment Unveils Inclusive Summer Package, Bringing Big Value to Harrah's Las Vegas, The LINQ Hotel and Flamingo Las Vegas

     The package includes accommodations, taxes, resort fees, two meals per day at a variety of dining outlets, bottomless drinks, High Roller Observation Wheel tickets and free self-parking **For high-res photos of Harrah's Las Vegas, The LINQ Hotel and Flamingo Las Vegas, click here** Caesars Entertainment is offering its guests summer value options with the launch of its Inclusive Summer Package, a bundled hotel experience at Harrah's Las Vegas, The LINQ Hotel and Flamingo Las Vegas. Guests can book now at caesars.com/las-vegas/hotels/deals/inclusive-summer-package for stays in April 2026 through August 2026. The Inclusive Summer Package includes: A hotel stay in a standard room at

    4/2/26 3:14:00 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    Caesars Entertainment, Inc. to Report 2026 First Quarter Results on April 28, 2026

    Caesars Entertainment, Inc. (NASDAQ:CZR) will release its financial results for the first quarter after the market closes on Tuesday, April 28, 2026. The company will also host a conference call on the same date at 5:00 p.m. Eastern Time, 2:00 p.m. Pacific Time, to discuss its results and other matters related to the company. Participants may register for the call by clicking here. Once registered, participants will receive an email with the dial-in number and unique PIN number to access the live event. The call will also be accessible via webcast on the Investor Relations section of Caesars Entertainment's website or by visiting https://investor.caesars.com. A replay of the call will be

    4/1/26 4:01:00 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    $BHB
    $CZR
    $EXEL
    $PCB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler resumed coverage on Bar Harbor Bankshares with a new price target

    Piper Sandler resumed coverage of Bar Harbor Bankshares with a rating of Overweight and set a new price target of $38.00

    3/16/26 8:37:16 AM ET
    $BHB
    Major Banks
    Finance

    Exelixis downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Exelixis from Overweight to Equal-Weight and set a new price target of $48.00

    1/8/26 8:39:35 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Caesars Entertainment upgraded by Susquehanna with a new price target

    Susquehanna upgraded Caesars Entertainment from Neutral to Positive and set a new price target of $31.00

    1/8/26 8:01:24 AM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    $BHB
    $CZR
    $EXEL
    $PCB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-16) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 09/20/2023. Application Category: NDA, Application Number: 208692, Application Classification: Labeling

    9/21/23 4:37:02 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-14) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 07/14/2022. Application Category: NDA, Application Number: 208692, Application Classification: Efficacy

    7/15/22 4:38:40 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-12) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 09/17/2021. Application Category: NDA, Application Number: 208692, Application Classification: Efficacy

    9/20/21 3:53:29 PM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BHB
    $CZR
    $EXEL
    $PCB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Scully Joseph Patrick

    4 - BAR HARBOR BANKSHARES (0000743367) (Issuer)

    3/23/26 2:37:42 PM ET
    $BHB
    Major Banks
    Finance

    SEC Form 4 filed by Williams John Mogan

    4 - BAR HARBOR BANKSHARES (0000743367) (Issuer)

    3/23/26 2:36:54 PM ET
    $BHB
    Major Banks
    Finance

    SEC Form 4 filed by Shaw Brian D

    4 - BAR HARBOR BANKSHARES (0000743367) (Issuer)

    3/23/26 2:34:31 PM ET
    $BHB
    Major Banks
    Finance

    $BHB
    $CZR
    $EXEL
    $PCB
    SEC Filings

    View All

    SEC Form DEFA14A filed by PCB Bancorp

    DEFA14A - PCB BANCORP (0001423869) (Filer)

    4/9/26 4:10:43 PM ET
    $PCB
    Major Banks
    Finance

    SEC Form DEF 14A filed by PCB Bancorp

    DEF 14A - PCB BANCORP (0001423869) (Filer)

    4/9/26 4:05:19 PM ET
    $PCB
    Major Banks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Exelixis Inc.

    SCHEDULE 13G/A - EXELIXIS, INC. (0000939767) (Subject)

    3/26/26 6:23:12 PM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BHB
    $CZR
    $EXEL
    $PCB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lee Sang Young bought $190,582 worth of shares (8,590 units at $22.19) (SEC Form 4)

    4 - PCB BANCORP (0001423869) (Issuer)

    3/6/26 4:26:48 PM ET
    $PCB
    Major Banks
    Finance

    Director Lee Sang Young bought $47,524 worth of shares (2,092 units at $22.72) (SEC Form 4)

    4 - PCB BANCORP (0001423869) (Issuer)

    3/4/26 5:22:11 PM ET
    $PCB
    Major Banks
    Finance

    Director Colter David M bought $16,270 worth of shares (500 units at $32.54), increasing direct ownership by 4% to 12,687 units (SEC Form 4)

    4 - BAR HARBOR BANKSHARES (0000743367) (Issuer)

    3/3/26 12:46:35 PM ET
    $BHB
    Major Banks
    Finance

    $BHB
    $CZR
    $EXEL
    $PCB
    Leadership Updates

    Live Leadership Updates

    View All

    Scorpions Return to Las Vegas With New Headlining Residency at PH Live at Planet Hollywood Resort & Casino Celebrating the Band's 60th Anniversary

    SCORPIONS – COMING HOME TO LAS VEGAS 60+ YEARS OF SCORPIONS SEPTEMBER 17 – OCTOBER 3, 2026 WITH SPECIAL GUEST BUCKCHERRY Presales begin Wednesday, Feb. 18 General on sale begins Saturday, Feb. 21 Scorpions, one of the most iconic and influential hard rock bands of all time, are returning to PH Live at Planet Hollywood Resort & Casino in 2026 with a new headlining residency show. Promoted by Live Nation and Caesars Entertainment, Scorpions – Coming Home to Las Vegas will take place from Thursday, Sept. 17 through Saturday, Oct. 3, 2026, and will once again feature special guest Buckcherry. The new residency follows the band's three previous sold-out runs at the venue: Scorpions – Sin C

    2/17/26 10:00:00 AM ET
    $CZR
    $LYV
    Hotels/Resorts
    Consumer Discretionary
    Services-Misc. Amusement & Recreation

    Caesars Entertainment, Inc. Board Member Don Kornstein Announces Intention to Retire

    Caesars Entertainment, Inc. (NASDAQ:CZR) announced that Don Kornstein has informed the company that he intends to retire as Vice Chair of the Board effective Dec. 31, 2025. "On behalf of the entire board, we thank Don for his many important contributions, dedication and stewardship, and we wish him well in his future endeavors," said Gary Carano, Caesars Entertainment Executive Chairman. "Don has had a tremendous impact on Caesars, which is highlighted by his leadership and wise counsel relating to company and board matters," said Tom Reeg, Chief Executive Officer and member of the Board. "On behalf of the entire executive management team, we thank Don for his many valuable contributions

    12/3/25 4:00:00 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners

    DIAMOND BAR, Calif., Oct. 21, 2025 /PRNewswire/ -- The Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of innovative treatment options for patients with follicular lymphoma (FL)., today announced the appointments of Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners. "I believe Carol and Mehrdad will be exceptional partners to the IFLI team and portfolio as they bring decades of strategic leadership and drug development expertise," said David McCullagh, Man

    10/21/25 8:05:00 AM ET
    $CRVS
    $DNA
    $EXEL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $BHB
    $CZR
    $EXEL
    $PCB
    Financials

    Live finance-specific insights

    View All

    Caesars Entertainment, Inc. to Report 2026 First Quarter Results on April 28, 2026

    Caesars Entertainment, Inc. (NASDAQ:CZR) will release its financial results for the first quarter after the market closes on Tuesday, April 28, 2026. The company will also host a conference call on the same date at 5:00 p.m. Eastern Time, 2:00 p.m. Pacific Time, to discuss its results and other matters related to the company. Participants may register for the call by clicking here. Once registered, participants will receive an email with the dial-in number and unique PIN number to access the live event. The call will also be accessible via webcast on the Investor Relations section of Caesars Entertainment's website or by visiting https://investor.caesars.com. A replay of the call will be

    4/1/26 4:01:00 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    Gaming and Leisure Properties, Inc. Reports Record Fourth Quarter Results, Establishes 2026 Guidance and Declares 2026 First Quarter Dividend of $0.78 per Share

    WYOMISSING, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) ("GLPI" or the "Company") today announced record results for the fourth quarter and year-ended December 31, 2025. GLPI has posted a supplemental earnings presentation, which highlights the events of the quarter, recent developments, and future considerations, that can be accessed at www.glpropinc.com. Financial Highlights   Three Months Ended December 31, Year Ended December 31,(in millions, except per share data)  2025   2024   2025   2024 Total Revenue $407.0  $389.6  $1,594.8  $1,531.5 Income From Operations $363.4  $308.2  $1,201.5  $1,130.7 Net income $275.4  $223.6  $850.4  $807.6 FF

    2/19/26 4:15:00 PM ET
    $BALY
    $BYD
    $CZR
    Hotels/Resorts
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    Caesars Entertainment, Inc. Reports Fourth Quarter and Full Year 2025 Results

    Caesars Entertainment, Inc., (NASDAQ:CZR) ("Caesars," "CZR," "CEI" or "the Company") today reported operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter Results: GAAP net revenues of $2.9 billion versus $2.8 billion for the comparable prior-year period. GAAP net loss of $250 million compared to net income of $11 million for the comparable prior-year period, with the decrease primarily driven by gains on asset sales in the prior year period of over $350 million. Same-store Adjusted EBITDA of $901 million versus $882 million for the comparable prior-year period. Caesars Digital Adjusted EBITDA of $85 million versus $20 million for the co

    2/17/26 4:01:00 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    $BHB
    $CZR
    $EXEL
    $PCB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Caesars Entertainment Inc.

    SC 13G - Caesars Entertainment, Inc. (0001590895) (Subject)

    11/14/24 11:11:27 AM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    SEC Form SC 13G filed by Caesars Entertainment Inc.

    SC 13G - Caesars Entertainment, Inc. (0001590895) (Subject)

    11/14/24 10:31:43 AM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Caesars Entertainment Inc.

    SC 13G/A - Caesars Entertainment, Inc. (0001590895) (Subject)

    11/12/24 12:52:28 PM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary